Drug Treatment - Cytostatics
Cytostatics, which destroy cancer cells, play a central role in the type of cancer treatment known as chemotherapy.
Cytostatics are administered intravenously or in tablet form and are carried in the blood circulation to all parts of the body. Cytostatics act in a variety of ways, but all of them are aimed at destroying cancer cells by inducing changes in the cells’ genes or metabolism. Cytostatics affect all dividing cells in the body. Cancer tissue usually has a considerably higher cell division rate than normal tissue, and cancer cells are therefore exposed to significantly greater damage.
Cytostatic chemotherapy is repeated at regular intervals to ensure that the cancer tissue does not recover between treatments while healthy tissue does. As a result, the number of cancer cells decreases with each treatment cycle. If they are few in number (e.g. the small number of cancer cells remaining after surgical tumour removal), the patient may be completely cured of cancer.
The duration of cancer chemotherapy varies individually depending on whether the patient is receiving adjuvant therapy following surgery or radiotherapy, or whether the cancer is metastatic and has spread to other organs. In the former case, cancer chemotherapy typically lasts 4 to 6 months.
In cancer treatment the results are closely monitored by means of imaging (radiological scans). With some cancers, tumour biomarkers may be measured from a blood sample. The levels of biomarkers in blood vary depending on cancer activity.
In practice, intravenous chemotherapy is usually repeated every three weeks. However, in some cases treatment may be given as often as once a week. Each cytostatic agent is administered in a manner that experience has shown to be safe. Administration takes anything from 30 minutes to several hours. Treatment is often closely accompanied by a combination of premedications used to reduce adverse effects. Intravenous fluid administration is also common.
At Docrates Cancer Center, cancer chemotherapy is administered by experienced and specially trained nurses under the immediate supervision of a physician. The nurses also provide patients with information and guidance. They monitor the patient’s condition between treatments and answer any questions, for example on how to alleviate the adverse effects of chemotherapy.
Internal radiotherapy is an effective method of treatment for metastatic prostate cancer
14.3.2023 | Docrates Cancer Center studied the effectiveness of 177Lu-PSMA treatment with a 4-week treatment interval for patients with metastatic...Read more
The number of insured patients has more than tripled in five years
9.3.2023 | In 2022, nearly 30% of revenue generated by Docrates Cancer Center’s Finnish patients came from insurance company customers,...Read more
Docrates joins EAU23 – Europe’s biggest urological event 10 – 13 March, 2023 in Milan
8.3.2023 | Docrates Cancer Center participates to EAU23 – the Europe’s biggest urological event, which will be held on 10-13...Read more
COVID-19 – Information and guidelines
14.3.2023 | In the aftermath of the COVID-19 pandemic, we have abandoned the most robust protective measures. On this page,...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
Mon-Thu 8 am-6 pm, Fri 8 am-4 pm (local time)